Asset
SAFINAMIDE MESYLATE
Supernus Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (0)
No records yet.
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 207145 | NDA | MDD US OPERATIONS LLC |
Marketed products (2)
- XADAGO
- XADAGO